Yasutoshi Fujii

Yasutoshi Fujii

Auto-generated profile, based on publicly available information

Yasutoshi Fujii

Division of Clinical Oncology, Hiroshima Prefectural Hospital, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in International Cancer Conference Journal
Verified
Journal Article
Closed access
PDF file
YFYasutoshi Fujii
Yasutoshi Fujii
MDMihoko Doi
Mihoko Doi
NTNaofumi Tsukiyama
Naofumi Tsukiyama
YHYui Hattori
Yui Hattori
KOKazuki Ohya
Kazuki Ohya
KCKazuaki Chayama
Kazuaki Chayama

30 January 2008 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
TNTakeshi Nagasaka
Takeshi Nagasaka
YFY. Fujii
Y. Fujii
AIA. Ishida
A. Ishida
MHM. Handa
M. Handa
ATA. Tanikawa
A. Tanikawa
TNT. Nishikawa
T. Nishikawa

1 July 2020 in Internal Medicine
Verified
Journal Article
Open access
PDF file
YFYasutoshi Fujii
Yasutoshi Fujii
MDMihoko Doi
Mihoko Doi
HYHiroaki Yamane
Hiroaki Yamane
TMTakehiko Morioka
Takehiko Morioka
DKDaisuke Komichi
Daisuke Komichi
KSKatsunori Shinozaki
Katsunori Shinozaki
Immunoglobulin G4-related disease (IgG4-RD) is defined as an inflammatory lymphoproliferative disorder. The relationship between malignancies and IgG4-RD remains unclear. We herein present a case of IgG4-RD that occurred during chemotherapy for advanced breast cancer. In this case, it was challenging to determine which of these diseases was responsible for the patient's mediastinal lymphadenopathy. Lymphadenopathy with IgG4-RD was diagnosed by assessing the reactivity to corticosteroids, which were used as premedication in chemotherapy, over time. The administration of prednisolone, which was initiated to treat active IgG4-RD, led to stable systemic therapy for malignancy. It is imperative to assess the disease activity and consider each treatment.